Breaking News

Illumina partners 54gene for creation of world-class genomics facility in Nigeria

Partnership will expand 54gene’s sequencing-based research and molecular diagnostics capabilities with a focus on improving health outcomes through precision medicine Illumina, Inc. (NASDAQ: ILMN), Thursday, announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The partnership will
Read More

Do NOT follow this link or you will be banned from the site!